Ayass Bioscience
BiRAGAS an agentic Ai bioinformatics platform
Contact this company →
Available to registered investors only
Something went wrong. Please try again.
About the company
About Ayass Bioscience
Biotech invented new software a causal inference for drug discovery , it is an agentic Ai bioinformatics platform that addresses the 3 major problems, the wrong molecular target, the wrong patient stratification for clinical trial and the wrong analytic platform. BiRAGAS can solve them all. It is a causality based outcome with 24 modules
Fundraise details
Fundraise details are for investors only.
Funding needed, monthly income, the offering terms and the founder's documents are visible to registered accredited investors.